Published in J Interferon Cytokine Res on February 12, 2013
SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells. J Virol (2015) 0.78
Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS One (2015) 0.77
Pre-Infection Transcript Levels of FAM26F in PBMCS Inform about Overall Plasma Viral Load in Acute and Postacute Phase after SIV-Infection. J Gen Virol (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics (2007) 12.76
The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 10.90
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science (1986) 9.17
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity (2007) 6.66
Interferons, interferon-like cytokines, and their receptors. Immunol Rev (2004) 6.21
Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology (1985) 6.08
Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet (1985) 3.03
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today (1996) 3.01
Retracted Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science (2002) 2.81
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest (1991) 2.40
A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology (1989) 2.33
INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res (2008) 2.31
CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A (1995) 2.27
Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol (1975) 2.09
CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog (2010) 1.99
Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood (1999) 1.97
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog (2010) 1.90
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res (1986) 1.83
ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res (2010) 1.75
Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol (1991) 1.72
Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol (1994) 1.70
Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol (2005) 1.57
Understanding the structure and function of the immunological synapse. Cold Spring Harb Perspect Biol (2010) 1.54
The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol (2003) 1.49
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog (2010) 1.48
Interferon-alpha drives monocyte gene expression in chronic unsuppressed HIV-1 infection. AIDS (2010) 1.34
Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses (1987) 1.31
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood (2011) 1.25
Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment. AIDS (2006) 1.16
CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol (1991) 1.15
Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody. J Immunol (1970) 1.11
Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest (1997) 1.07
Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res Hum Retroviruses (1995) 1.04
HIV replication can be blocked by recombinant human interferon beta. AIDS (1989) 1.04
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol (2002) 1.03
Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L. J Virol (1998) 1.02
Microarray data analysis and mining approaches. Brief Funct Genomic Proteomic (2008) 1.02
The differential activity of interferon-α subtypes is consistent among distinct target genes and cell types. Cytokine (2010) 0.96
Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells. J Virol (2010) 0.96
CD8+ T cell control of HIV--a known unknown. PLoS Pathog (2010) 0.94
The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proc Natl Acad Sci U S A (2003) 0.92
In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha. J Acquir Immune Defic Syndr (1991) 0.92
Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha. J Interferon Res (1992) 0.91
HIV/AIDS: 30 years of progress and future challenges. Eur J Immunol (2011) 0.90
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood (2002) 0.89
Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases. Proc Natl Acad Sci U S A (2012) 0.88
Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol (1998) 0.88
A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses. J Immunol Methods (2005) 0.84
Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. Blood (2003) 0.83
Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha. Antiviral Res (1993) 0.82
Expression of IFN A genes in subpopulations of peripheral blood cells. Br J Haematol (1994) 0.81
CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy. J Clin Immunol (2009) 0.79
Fas and Fas ligand are not involved in the suppression of HIV replication by CD8 cells. AIDS (2000) 0.78
Transfection optimization for primary human CD8+ cells. J Immunol Methods (2011) 0.76
Inhibitory effect of interleukin-10 on human leukocyte interferon-alpha production by Sendai virus. Cytokines Cell Mol Ther (1998) 0.76
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
High frequency of BRAF mutations in nevi. Nat Genet (2002) 9.95
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics (2007) 6.67
DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Methods (2006) 6.25
MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13
Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci U S A (2004) 3.82
Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature (2011) 3.56
Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell (2008) 3.42
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med (2004) 2.90
Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol Cell Biol (2003) 2.70
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res (2005) 2.64
Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet (2006) 2.62
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol (2012) 2.61
Cancer genomics: small RNAs with big impacts. Nature (2005) 2.55
The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res (2013) 2.27
Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet (2013) 2.21
Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics (2002) 2.19
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov (2013) 2.11
Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res (2008) 2.01
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell (2011) 1.96
No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science (2011) 1.90
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res (2003) 1.81
A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell (2013) 1.75
Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res (2010) 1.74
Expression profiling to predict outcome in breast cancer: the influence of sample selection. Breast Cancer Res (2002) 1.72
GEOmetadb: powerful alternative search engine for the Gene Expression Omnibus. Bioinformatics (2008) 1.68
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology (2011) 1.68
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab (2012) 1.67
An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol (2005) 1.67
Kinetic complexity of the global response to glucocorticoid receptor action. Endocrinology (2009) 1.64
Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet (2003) 1.59
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res (2009) 1.58
Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis (2002) 1.50
Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras. Cell Cycle (2008) 1.48
Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol (2002) 1.46
Genome-wide depletion of replication initiation events in highly transcribed regions. Genome Res (2011) 1.44
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat (2008) 1.44
Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res (2009) 1.40
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res (2009) 1.36
Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. Cancer Res (2007) 1.35
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol (2002) 1.32
A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell (2002) 1.32
Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol (2011) 1.31
Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol (2006) 1.28
SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions. Cancer Biol Ther (2004) 1.24
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene (2004) 1.18
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Haematologica (2011) 1.16
Expression and mutational status of c-kit in thymic epithelial tumors. J Thorac Oncol (2010) 1.15
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol Cancer Res (2009) 1.14
CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med (2004) 1.14
SRAdb: query and use public next-generation sequencing data from within R. BMC Bioinformatics (2013) 1.13
Focus on sarcomas. Cancer Cell (2002) 1.12
Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep (2003) 1.12
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. Genome Res (2013) 1.11
A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol (2013) 1.10
Molecular grading of ductal carcinoma in situ of the breast. Clin Cancer Res (2008) 1.09
Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab (2004) 1.09
Molecular characterization of putative chordoma cell lines. Sarcoma (2010) 1.09
Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry. Am J Dermatopathol (2006) 1.09
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. Mol Cancer Ther (2004) 1.07
M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology (2002) 1.06
The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. Cancer Res (2006) 1.06
Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res (2012) 1.05
Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Res (2010) 1.05
Polycomb repressor complex-2 is a novel target for mesothelioma therapy. Clin Cancer Res (2011) 1.04
Preferential localization of human origins of DNA replication at the 5'-ends of expressed genes and at evolutionarily conserved DNA sequences. PLoS One (2011) 1.04
A chromatin structure-based model accurately predicts DNA replication timing in human cells. Mol Syst Biol (2014) 1.04
Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J Mol Diagn (2010) 1.02
Functional genomics of UV radiation responses in human cells. Mutat Res (2004) 0.99
Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma. Blood (2012) 0.96
Lucky draw in the gene raffle. Nature (2002) 0.96
Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells. J Virol (2010) 0.96
Zoom-in comparative genomic hybridisation arrays for the characterisation of variable breakpoint contiguous gene syndromes. J Med Genet (2006) 0.95
Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol (2009) 0.95
Serum proteomics in cancer diagnosis and management. Annu Rev Med (2004) 0.93
A probe-density-based analysis method for array CGH data: simulation, normalization and centralization. Bioinformatics (2008) 0.93
Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion. Cell Cycle (2014) 0.92
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med (2015) 0.91
Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype. J Clin Endocrinol Metab (2013) 0.90
Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. J Neurotrauma (2011) 0.90